Validating an AI tool in a GxP clinical environment means demonstrating that it reliably does what it is intended to do, within a defined context, at a level of assurance proportionate to the risk of its outputs. Traditional computer system validation provides the foundation, but AI adds challenges around variability, training data and model drift.
Sponsors are often handed a vendor's validation package and told the tool is validated. That package may be sound. It may also validate a general capability rather than the specific use on your trial.
How is AI validation different from traditional system validation?
Conventional software is deterministic. The same input produces the same output, so testing against predefined scripts works well. Many AI systems are probabilistic. Outputs may vary, performance depends on the data the model sees, and behavior can change when the model is retrained.
That means validation must address questions traditional CSV rarely asked:
Is the training and test data representative of the data this tool will see in our trial?
What is the tool's measured performance (accuracy, sensitivity, false positive rate) for our intended use?
How is performance monitored over time to detect drift?
How are model updates assessed before they reach production?
For generative AI, how are errors such as fabricated content detected?
Define the context of use
FDA's January 2025 draft guidance on AI to support regulatory decision-making centers on context of use and a risk-based credibility assessment. The model risk depends on how much the AI output influences a decision and how serious the consequences of a wrong decision would be. That framing is useful for sponsors even for operational tools outside its direct scope.
In practice, write down the question the tool answers, the decision it informs and what happens if it is wrong. That statement drives how much evidence you need.
Risk-based, not one-size-fits-all
A generative AI tool that drafts internal meeting summaries needs basic controls and an acceptable use policy. A model that classifies adverse event seriousness needs rigorous validation, defined performance thresholds and ongoing monitoring. Applying the heaviest validation to everything wastes resources. Applying the lightest to everything creates risk.
What to request from vendors
Ask for the validation summary tied to your intended use, performance metrics on representative data, the change control procedure for model updates, and how audit trails capture AI-assisted actions. If the vendor's validation was performed on a different use case, you may need supplementary testing.
Validation is not a one-time certificate. For AI, it is an ongoing demonstration that the tool still deserves your trust.
